MRNA
Price
$214.53
Change
+$0.80 (+0.37%)
Updated
Oct 13, 01:46 PM (EDT)
Capitalization
78.76B
16 days until earnings call
Intraday BUY SELL Signals
TWST
Price
$153.94
Change
+$2.07 (+1.36%)
Updated
Oct 13, 01:28 PM (EDT)
Capitalization
11.91B
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MRNA vs TWST

MRNA vs TWST Comparison Chart in %
View a ticker or compare two or three
VS
MRNA vs. TWST commentary
Oct 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNA is a StrongBuy and TWST is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
MRNA vs TWST: Fundamental Ratings
MRNA
TWST
OUTLOOK RATING
1..100
4182
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
134
P/E GROWTH RATING
1..100
3100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (70) in the Biotechnology industry is in the same range as MRNA (79). This means that TWST’s stock grew similarly to MRNA’s over the last 12 months.

TWST's Profit vs Risk Rating (79) in the Biotechnology industry is in the same range as MRNA (100). This means that TWST’s stock grew similarly to MRNA’s over the last 12 months.

TWST's SMR Rating (97) in the Biotechnology industry is in the same range as MRNA (97). This means that TWST’s stock grew similarly to MRNA’s over the last 12 months.

MRNA's Price Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for TWST (34). This means that MRNA’s stock grew somewhat faster than TWST’s over the last 12 months.

MRNA's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for TWST (100). This means that MRNA’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRNATWST
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 13, 2026
Stock price -- (MRNA: $213.74 vs. TWST: $151.86)
Brand notoriety: MRNA: Notable vs. TWST: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNA: 58% vs. TWST: 92%
Market capitalization -- MRNA: $78.76B vs. TWST: $11.91B
MRNA [@Biotechnology] is valued at $78.76B. TWST’s [@Biotechnology] market capitalization is $11.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNA’s FA Score shows that 2 FA rating(s) are green while TWST’s FA Score has 0 green FA rating(s).

  • MRNA’s FA Score: 2 green, 3 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, MRNA is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNA’s TA Score shows that 4 TA indicator(s) are bullish while TWST’s TA Score has 3 bullish TA indicator(s).

  • MRNA’s TA Score: 4 bullish, 4 bearish.
  • TWST’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than TWST.

Price Growth

MRNA (@Biotechnology) experienced а +5.18% price change this week, while TWST (@Biotechnology) price change was -25.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.15%. For the same industry, the average monthly price growth was -13.64%, and the average quarterly price growth was -15.31%.

Reported Earning Dates

MRNA is expected to report earnings on Oct 29, 2026.

TWST is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (-5.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MRNA
Daily Signal:
Gain/Loss:
TWST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
GLM.X0.129878-0.005279
-3.91%
Golem cryptocurrency
FLUX.X0.083565-0.006253
-6.96%
Flux cryptocurrency
BCH.X265.470340-20.776215
-7.26%
Bitcoin Cash cryptocurrency
MOB.X0.051597-0.006482
-11.16%
MobileCoin cryptocurrency
IDEX.X0.000352-0.000088
-20.00%
IDEX cryptocurrency